bioTheranostics, Inc., a bioMerieux company that develops innovative oncology diagnostic tests to inform personalized treatment, today announced results from studies that demonstrated the increased clinical utility of the Breast Cancer Index(SM) (BCI). These studies suggest that BCI, with its novel mechanism of action, provides oncologists with insight into the risk of late recurrence for estrogen [...]
Dec 14 2011 | Posted in
Cancer Research |
Read More »
A large, retrospective study shows that children of childhood cancer survivors who received prior treatment involving radiation to testes or ovaries and/or chemotherapy with alkylating agents do not have an increased risk for birth defects compared to children of survivors who did not have such cancer treatment. The findings provide reassurance that increased risks of [...]
Dec 13 2011 | Posted in
Cancer Research |
Read More »
A new analysis has found that breast cancer survivors may experience problems with certain mental abilities several years after treatment, regardless of whether they were treated with chemotherapy plus radiation or radiation only. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that there may be common and [...]
Dec 12 2011 | Posted in
Cancer Research |
Read More »
Obese patients with early-stage HER2-positive breast cancer may have worse outcomes than patients who are normal weight or overweight, Mayo Clinic researchers found in a study presented today at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium. HER2-positive breast cancer gets its name from a protein called human epidermal growth factor receptor 2 that promotes [...]
Dec 8 2011 | Posted in
Cancer Research |
Read More »
One study presented at the meeting, which is being held in Budapest, Hungary, 7 to 10 December, reports on an initiative using echocardiography to document early warning signs of adverse effects from trastuzumab (Herceptin ®)¹, while the other uses echocardiography to evaluate the protective role of ACE inhibitors and statins on the hearts of cancer [...]
Dec 7 2011 | Posted in
Cancer Research |
Read More »
Men are three times more likely than women to develop a common form of skin cancer but medical science doesn’t know why. A new study may provide part of the answer. Researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) [...]
Dec 2 2011 | Posted in
Cancer Research |
Read More »
Scientists have designed a first draft of a mathematical model that someday could guide treatment decisions for advanced prostate cancer, in part by helping doctors predict how individual patients will respond to therapy based on the biology of their tumors. These decisions would apply to treatment of cancer that has already spread beyond the prostate [...]
Nov 22 2011 | Posted in
Cancer Research |
Read More »
CHICAGO – Carbon dioxide laser ablation (removal) may have a role as an alternative treatment for a common precancerous skin lesion known as lentigo maligna when surgery or radiation therapy is not feasible, according to a report in the November/December issue of the Archives of Facial Plastic Surgery, one of the JAMA/Archives journals. According to [...]
Nov 21 2011 | Posted in
Cancer Research |
Read More »
The development of simple tests to predict a leukemic relapse in young patients is a step closer thanks to researchers from the Sainte-Justine University Hospital Research Center and the University of Montreal. Approximately 20 percent of young leukemia patients who are treated with stem cells derived from umbilical cord blood will experience leukemic relapse. The [...]
Nov 17 2011 | Posted in
Cancer Research |
Read More »
Researchers in the United States have shown, for the first time, that it is possible to screen cancer patients for a broad range of cancer-causing genetic mutations as part of normal clinical practice. By identifying patients’ individual genotypes within a relatively short time frame, doctors are able to target tumours with the most appropriate therapy. [...]
Nov 9 2011 | Posted in
Cancer Research |
Read More »
